Trial intelligence / Profile preview

Intradermal LPS to study vascular responses

NL-OMON59210Phase 1Completed

Sponsor
Centre for Human Drug Research
Start
May 2024
Countries
1
01

Overview

Phase 1, single-arm trial of lipopolysaccharide endotoxin, sponsored by Centre for Human Drug Research. Started May 2024; status: completed.

02

Drugs

lipopolysaccharide endotoxin

Beyond the preview

Go deeper on NL-OMON59210.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON59210.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call